-
Medical expert committee to review BNT162b2 vaccine The coronavirus (COVID-19) vaccine created by U.S. pharmaceutical company Pfizer and German drugmaker Bio’N’Tech is set for a final review for emergency use by the FDA. If...
-
Pfizer and Bio’N’Tech will be the first to offer COVID-19 vaccine in the U.S. After months of research and rapid development, Pfizer and Bio’N’Tech secured authorization for emergency use from the FDA and CDC...
-
Moderna Inc. requests authorization for COVID-19 vaccine Moderna Inc. requests authorization of emergency use for the coronavirus (COVID-19) vaccine with regulators in the U.S. and Europe. This request follows the exciting and promising results...
-
Pfizer and BioNTech planning for FDA approval for COVID-19 vaccine Pfizer and BioNTech apply for emergency use authorization of their potential coronavirus (COVID-19) vaccine with the FDA. The Food and Drug Administration will process...
-
Moderna Inc. announces successful study for COVID-19 vaccine Moderna Inc. released the latest data from its late-stage trial for its experimental coronavirus (COVID-19) vaccine, mRNA-1273, proving to be 94.5% effective in preventing COVID-19 infection....
-
The COVID-19 vaccine should be available by the end of 2020 The U.S. government just made a $1.95 billion deal with Pfizer Inc. and BioNTech SE to secure the first 600 million doses of...